EAT is up +49.38%% since April’24 pick View All Top Buy Picks
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 4536.T
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

SANTEN PHARMACEUTICAL CO.,LTD. stock downgraded from Strong Buy Candidate to Buy Candidate after Thursday trading session.
(Updated on Jun 27, 2024)

Buy candidate since Jun 24, 2024 Gain 0.22% PDF

The SANTEN PHARMACEUTICAL CO.,LTD. stock price fell by -1.93% on the last day (Thursday, 27th Jun 2024) from JP¥1,659.00 to JP¥1,627.00. During the last trading day the stock fluctuated 1.36% from a day low at JP¥1,616.00 to a day high of JP¥1,638.00. The price has risen in 6 of the last 10 days and is up by 3.56% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -412 thousand shares and in total, 953 thousand shares were bought and sold for approximately JP¥1.55 billion.

The stock lies in the middle of a narrow and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.31% during the next 3 months and, with a 90% probability hold a price between JP¥1,819.90 and JP¥1,900.32 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

4536.T Signals & Forecast

The SANTEN PHARMACEUTICAL CO.,LTD. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at JP¥1,616.93 and JP¥1,603.74. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, June 26, 2024, and so far it has fallen -1.93%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for SANTEN PHARMACEUTICAL CO.,LTD. stock

On the downside, the stock finds support just below today's level from accumulated volume at JP¥1,512.50 and JP¥1,486.50. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, SANTEN PHARMACEUTICAL CO.,LTD. finds support just below today's level at JP¥1,512.50. If this is broken, then the next support from accumulated volume will be at JP¥1,486.50 and JP¥1,420.00.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved JP¥22.00 between high and low, or 1.36%. For the last week the stock has had daily average volatility of 1.80%.

Our recommended stop-loss: JP¥1,555.06 (-4.42%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (4536.T) For The Upcoming Trading Day Of Friday 28th

For the upcoming trading day on Friday, 28th we expect SANTEN PHARMACEUTICAL CO.,LTD. to open at JP¥1,627.00, and during the day (based on 14 day Average True Range), to move between JP¥1,593.57 and JP¥1,660.43, which gives a possible trading interval of +/-JP¥33.43 (+/-2.05%) up or down from last closing price. If SANTEN PHARMACEUTICAL CO.,LTD. takes out the full calculated possible swing range there will be an estimated 4.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at JP¥1,628.00 (0.06%) than the support at JP¥1,512.50 (7.04%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is SANTEN PHARMACEUTICAL CO.,LTD. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for SANTEN PHARMACEUTICAL CO.,LTD. stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 3.251 Buy Candidate Downgraded

Predicted Opening Price for SANTEN PHARMACEUTICAL CO.,LTD. of Friday, June 28, 2024

Fair opening price June 28, 2024 Current price
JP¥1,627.00 ( 0%) JP¥1,627.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 4536.T

Fibonacci Support & Resistance Levels

Level Price
R3 1,649.00 1.35%
R2 1,640.60 0.84%
R1 1,635.40 0.517%
Price 1,627.00
S1 1,618.60 -0.517%
S2 1,613.40 -0.84%
S3 1,605.00 -1.35%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1,648.00 1.29%
R2 1,632.00 0.307%
R1 1,628.00 0.0615%
Price 1,627.00
S1 1,512.50 -7.04%
S2 1,486.50 -8.64%
S3 1,420.00 -12.72%

4536 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 27, 2024 Sep 27, 2024 Sep 27, 2024 JP¥0 0%
2 Mar 28, 2024 Mar 28, 2024 Jun 26, 2024 JP¥17.00 1.02%
3 Sep 28, 2023 Sep 28, 2023 Nov 30, 2023 JP¥16.00 1.14%
4 Mar 30, 2023 Mar 30, 2023 Mar 30, 2023 JP¥16.00 1.43%
5 Sep 29, 2022 Sep 29, 2022 Sep 29, 2022 JP¥16.00 1.62%

FAQ

What is the symbol for SANTEN PHARMACEUTICAL CO.,LTD. Stock and on which exchange is it traded?
The symbol for SANTEN PHARMACEUTICAL CO.,LTD. is 4536.T and it is traded on the TYO (Tokyo Stock Exchange).

Should I buy or sell SANTEN PHARMACEUTICAL CO.,LTD. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for SANTEN PHARMACEUTICAL CO.,LTD. stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

How to buy SANTEN PHARMACEUTICAL CO.,LTD. Stock?
SANTEN PHARMACEUTICAL CO.,LTD. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy SANTEN PHARMACEUTICAL CO.,LTD. Stock.

What's the current price of SANTEN PHARMACEUTICAL CO.,LTD. Stock?
As of the end of day on the Jun 27, 2024, the price of an SANTEN PHARMACEUTICAL CO.,LTD. (4536.T) share was JP¥1,627.00.

What is the 52-week high and low for SANTEN PHARMACEUTICAL CO.,LTD. Stock?
The 52-week high for SANTEN PHARMACEUTICAL CO.,LTD. Stock is JP¥1,670.00 and the 52-week low is JP¥1,165.50.

What is the market capitalization of SANTEN PHARMACEUTICAL CO.,LTD. Stock?
As of the Jun 27, 2024, the market capitalization of SANTEN PHARMACEUTICAL CO.,LTD. is 602.564B.

When is the next earnings date for SANTEN PHARMACEUTICAL CO.,LTD.?
The upcoming earnings date for SANTEN PHARMACEUTICAL CO.,LTD. is Aug 01, 2024.
Click to get the best stock tips daily for free!

About SANTEN PHARMACEUTICAL CO.,LTD.

SANTEN PHARMACEUTICAL Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that... 4536.T Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT